Stroke prevention in atrial fibrillation: better use of anticoagulation and new agents will lead to improved outcomes
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Competing interests: Declared. SJC receives major research grants related to atrial fibrillation from Sanofi-Aventis, Bristol-Myers Squibb, Boehringer Ingelheim and Portola Pharmaceuticals.